当前位置: X-MOL 学术Biotechnol. Law Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
New President, New Human Embryonic Stem Cell Research Policy: Comparative International Perspectives and Embryonic Stem Cell Research Laws in France*
Biotechnology Law Report ( IF 0.2 ) Pub Date : 2013-12-01 , DOI: 10.1089/blr.2013.9865
By Katherine Drabiak-Syed

Abstract This article provides an overview of French legislative history, Parliamentary debates, and recent amendments in hESC research policy, as well as additional comparisons with laws across the European Union. Unlike policy discussions in the U.S., French dialogue on hESC research generally rejects the arbitrary division between the status of the embryo and hESCs, recognizing that hESC research necessarily requires the destruction of human embryos. Accordingly, French discourse debates the competing interests of science with secular ethical and civic considerations relating to the symbolic status of the embryo and society's duty to moderate what constitutes appropriate boundaries on research. Parliament recently amended France's hESC research laws to explicitly permit hESC research, signaling the beginning of reform efforts under President Hollande's new power structure, but the inclusion of secular moral considerations in the policy debate will likely restrain the extent of any future changes.

中文翻译:

新人类胚胎干细胞研究政策的新主席:比较国际视角和法国胚胎干细胞研究法律*

摘要 本文概述了法国的立法历史、议会辩论和 hESC 研究政策的最新修订,以及与整个欧盟法律的其他比较。与美国的政策讨论不同,法国关于 hESC 研究的对话一般拒绝在胚胎状态和 hESC 之间任意划分,认识到 hESC 研究必然需要破坏人类胚胎。相应地,法国话语以世俗伦理和公民考虑来讨论科学的竞争利益,这些考虑涉及胚胎的象征地位以及社会调节什么构成研究的适当边界的责任。议会最近修改了法国的 hESC 研究法,明确允许 hESC 研究,
更新日期:2013-12-01
down
wechat
bug